| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Human Cancer Biology |
Authors' Affiliations: 1 Molecular Oncology, 2 Pathology, 3 Experimental Therapeutics, 4 Biostatistics, and 5 Comprehensive Breast Cancer Programs, H. Lee Moffitt Cancer Center and Research Institute Department of Interdisciplinary Oncology, University of South Florida College of Medicine, Tampa, Florida
Requests for reprints: Richard Jove, Molecular Medicine and Experimental Therapeutics, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010. Phone: 626-301-8179; Fax: 626-256-4673; E-mail: rjove{at}coh.org.
Purpose: Signal transducer and activator of transcription 3 (Stat3) protein is persistently activated in breast cancer and promotes tumor cell survival. To gain a better understanding of the role of constitutive Stat3 signaling in breast cancer progression, we evaluated the expression profile of potential Stat3-regulated genes that may confer resistance to apoptosis.
Experimental Design: Stat3 signaling was blocked with antisense oligonucleotides in human MDA-MB-435s breast cancer cells and Affymetrix GeneChip microarray analysis was done. The candidate Stat3 target gene Survivin was further evaluated in molecular assays using cultured breast cancer cells and immunohistochemistry of breast tumor specimens.
Results: Survivin, a member of the inhibitor of apoptosis protein family, was identified as a potential Stat3-regulated gene by microarray analysis. This was confirmed in Survivin gene promoter studies and chromatin immunoprecipitation assays showing that Stat3 directly binds to and regulates the Survivin promoter. Furthermore, direct inhibition of Stat3 signaling blocked the expression of Survivin protein and induced apoptosis in breast cancer cells. Direct inhibition of Survivin expression also induced apoptosis. Increased Survivin protein expression correlates significantly (P = 0.001) with elevated Stat3 activity in primary breast tumor specimens from high-risk patients who were resistant to chemotherapy treatment.
Conclusions: We identify Survivin as a direct downstream target gene of Stat3 in human breast cancer cells that is critical for their survival in culture. Our findings suggest that activated Stat3 signaling contributes to breast cancer progression and resistance to chemotherapy by, at least in part, inducing expression of the antiapoptotic protein, Survivin.
This article has been cited by other articles:
|
|
 |
|
  S. R. Walker, E. A. Nelson, L. Zou, M. Chaudhury, S. Signoretti, A. Richardson, and D. A. Frank Reciprocal Effects of STAT5 and STAT3 in Breast Cancer Mol. Cancer Res., June 1, 2009; 7(6): 966 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhou, C. Bi, J. V. Janakakumara, S.-C. Liu, W.-J. Chng, K.-G. Tay, L.-F. Poon, Z. Xie, S. Palaniyandi, H. Yu, et al. Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML Blood, April 23, 2009; 113(17): 4052 - 4062. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. L P Beales and O. O Ogunwobi Glycine-extended gastrin inhibits apoptosis in Barrett's oesophageal and oesophageal adenocarcinoma cells through JAK2/STAT3 activation J. Mol. Endocrinol., April 1, 2009; 42(4): 305 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Proietti, C. Rosemblit, W. Beguelin, M. A. Rivas, M. C. Diaz Flaque, E. H. Charreau, R. Schillaci, and P. V. Elizalde Activation of Stat3 by Heregulin/ErbB-2 through the Co-Option of Progesterone Receptor Signaling Drives Breast Cancer Growth Mol. Cell. Biol., March 1, 2009; 29(5): 1249 - 1265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lee, J. Dhillon, M. Y.C. Wang, Y. Gao, K. Hu, E. Park, A. Astanehe, M.-C. Hung, P. Eirew, C. J. Eaves, et al. Targeting YB-1 in HER-2 Overexpressing Breast Cancer Cells Induces Apoptosis via the mTOR/STAT3 Pathway and Suppresses Tumor Growth in Mice Cancer Res., November 1, 2008; 68(21): 8661 - 8666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. W. Lee, C. M. Raskett, I. Prudovsky, and D. C. Altieri Molecular Dependence of Estrogen Receptor-Negative Breast Cancer on a Notch-Survivin Signaling Axis Cancer Res., July 1, 2008; 68(13): 5273 - 5281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kataoka, D. J. Kim, S. Carbajal, J. L. Clifford, and J. DiGiovanni Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis Carcinogenesis, June 1, 2008; 29(6): 1108 - 1114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. R. Fantin, A. Loboda, C. P. Paweletz, R. C. Hendrickson, J. W. Pierce, J. A. Roth, L. Li, F. Gooden, S. Korenchuk, X. S. Hou, et al. Constitutive Activation of Signal Transducers and Activators of Transcription Predicts Vorinostat Resistance in Cutaneous T-Cell Lymphoma Cancer Res., May 15, 2008; 68(10): 3785 - 3794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sekikawa, H. Fukui, S. Fujii, K. Ichikawa, S. Tomita, J. Imura, T. Chiba, and T. Fujimori REG I{alpha} protein mediates an anti-apoptotic effect of STAT3 signaling in gastric cancer cells Carcinogenesis, January 1, 2008; 29(1): 76 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Raj, T. Liu, G. Samadashwily, F. Li, and D. Grossman Survivin repression by p53, Rb and E2F2 in normal human melanocytes Carcinogenesis, January 1, 2008; 29(1): 194 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Guo, C. Mantel, R. A. Hromas, and H. E. Broxmeyer Oct-4 Is Critical for Survival/Antiapoptosis of Murine Embryonic Stem Cells Subjected to Stress: Effects Associated with Stat3/Survivin Stem Cells, January 1, 2008; 26(1): 30 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Duan, J. Bradner, E. Greenberg, R. Mazitschek, R. Foster, J. Mahoney, and M. V. Seiden 8-Benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic Acid (SD-1008), a Novel Janus Kinase 2 Inhibitor, Increases Chemotherapy Sensitivity in Human Ovarian Cancer Cells Mol. Pharmacol., November 1, 2007; 72(5): 1137 - 1145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pennati, M. Folini, and N. Zaffaroni Targeting survivin in cancer therapy: fulfilled promises and open questions Carcinogenesis, June 1, 2007; 28(6): 1133 - 1139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-C. Li, S.-L. Ye, R.-X. Sun, Y.-K. Liu, Z.-Y. Tang, Y. Kim, J. G. Karras, and H. Zhang Inhibition of Growth and Metastasis of Human Hepatocellular Carcinoma by Antisense Oligonucleotide Targeting Signal Transducer and Activator of Transcription 3 Clin. Cancer Res., December 1, 2006; 12(23): 7140 - 7148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Duan, J. E. Bradner, E. Greenberg, R. Levine, R. Foster, J. Mahoney, and M. V. Seiden SD-1029 Inhibits Signal Transducer and Activator of Transcription 3 Nuclear Translocation. Clin. Cancer Res., November 15, 2006; 12(22): 6844 - 6852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. W. Kim, R. W. Mutter, C. Cao, J. M. Albert, E. T. Shinohara, K. R. Sekhar, and B. Lu Inhibition of signal transducer and activator of transcription 3 activity results in down-regulation of Survivin following irradiation. Mol. Cancer Ther., November 1, 2006; 5(11): 2659 - 2665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Duan, R. Foster, D. A. Bell, J. Mahoney, K. Wolak, A. Vaidya, C. Hampel, H. Lee, and M. V. Seiden Signal Transducers and Activators of Transcription 3 Pathway Activation in Drug-Resistant Ovarian Cancer Clin. Cancer Res., September 1, 2006; 12(17): 5055 - 5063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Liby, N. Voong, C. R. Williams, R. Risingsong, D. B. Royce, T. Honda, G. W. Gribble, M. B. Sporn, and J. J. Letterio The Synthetic Triterpenoid CDDO-Imidazolide Suppresses STAT Phosphorylation and Induces Apoptosis in Myeloma and Lung Cancer Cells. Clin. Cancer Res., July 15, 2006; 12(14): 4288 - 4293. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
